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Abstract
Background: Behavioural support for smoking cessation in pregnancy can be effective; however, many pregnant
women face barriers to seeking support to stop smoking. Some digital interventions have been found to be
effective for smoking cessation in the general population and may be effective for supporting cessation in
pregnancy due to their flexibility and the potential for personalisation. To date, there is limited evidence of the
effectiveness of digital interventions for smoking cessation in pregnancy. This review aims to assess the following:
(1) whether digital interventions are effective at promoting smoking cessation among pregnant women; (2) which
behaviour change techniques (BCTs) or combinations of BCTs are associated with the effectiveness of digital
interventions for smoking cessation in pregnancy; and (3) whether the number of BCTs used is associated with the
effectiveness of digital interventions for smoking cessation in pregnancy.
Methods: This review will include digital interventions delivered largely through computer (PC or laptop), video/
DVD, mobile phone (including smartphones) or portable handheld device (e.g. tablet, iPad) and include websites,
mobile or tablet applications and SMS text messages. Interventions must be randomised or quasi-randomised
controlled trials aimed at women who smoke in pregnancy, with smoking cessation as a measured outcome
(preferably the latest available point prevalence smoking status measure taken during pregnancy, biochemically
verified if available). Electronic bibliographic databases will be searched to identify suitable studies indexed in the
following: Academic Search Complete, ASSIA, CINAHL, The Cochrane Library, EMBASE, Medline, PsycINFO, Scopus,
and Web of Science. The search strategy will include key words and database-specific subject headings relating to
‘pregnancy’ and ‘smoking’ and synonyms for the terms ‘digital’ and ‘randomised controlled trial’. Where required
and where possible, the first and second authors will independently code interventions and control groups for
BCTs. If data allows, meta-analyses will be used to assess intervention effectiveness and the effectiveness of BCTs.
Discussion: This systematic review will provide a detailed synthesis of the effectiveness of current research using
digital interventions for smoking cessation in pregnancy, to build on the evidence base and guide the
development of future research in this area.
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Background
Smoking in pregnancy is associated with a range of ad-
verse pregnancy outcomes, including placental compli-
cations, spontaneous abortion, foetal growth restriction
and low birth weight [1]. Prenatal exposure to tobacco
smoke increases the risks of still-birth [2] and congenital
birth defects, such as cardiovascular, musculoskeletal
and limb reduction defects [3]. Prenatal smoking also in-
creases the risks of childhood respiratory problems, in-
cluding recurrent wheeze and asthma [4], and of
developing nicotine dependence in adulthood [5]. Des-
pite a general reduction in pregnancy smoking rates in
high-income countries since the 1980s, this decline is
not falling at the same rate across all social groups [6].
Women from socially disadvantaged groups are more
likely to experience barriers to stopping smoking in
pregnancy, such as perceiving smoking to be the only
way of coping with stress and being influenced by their
peers [7], and are thus less likely to quit successfully be-
fore giving birth [8]. Smoking during pregnancy remains a
global health issue with huge variation in prevalence
across and within countries. In the USA, the rate of smok-
ing during pregnancy ranges across states from 1.8% in
California to 27.1% in West Virginia [9]. In England, the
rates of smoking at time of delivery also vary from 25.8%
in South Tyneside, north-east England, to 1.4% in West
London [10]. Across northern Europe, the rates of smok-
ing in early pregnancy have been reported to vary from
12.5% in Denmark, 16.5% in Norway, 15% in Finland and
6.9% in Sweden [11].
Psychosocial interventions for smoking cessation in
pregnancy can help to increase quit rates in the latter
stages of pregnancy and can reduce the risk of low birth
weight and preterm birth by up to 18% [12]. Other inter-
ventions, such as self-help [13], financial incentives [14],
telephone support [15], and pharmacological interventions
[16] have also demonstrated some efficacy for reducing
smoking in pregnancy. In the UK, pregnant women are
provided with free behavioural support to stop smoking
through the National Health Service (NHS). Pregnancy
specific support is provided by up to 67% of NHS services
in England, with an average 4-week quit rate of 45.5%
[17]. However, attendance at these services is low, and a
steady drop in quit rates has been seen since 2011/2012
[10, 18]. Fear of being judged, an issue of time constraints
and worry about failure have been reported as common
barriers to attending such services [19, 20]. Lack of know-
ledge regarding the benefits, general ethos and accessibil-
ity of services have also been identified as barriers to
accessing Stop Smoking Services [21]. This illustrates a
need to consider alternative approaches to providing
smoking cessation support for pregnant women [20].
There are currently 3.2 billion internet users and more
than 7 billion mobile phone subscriptions worldwide
[22]. Due to substantial improvements in public access
to usable technology, digital interventions, or interven-
tions which are mainly based around telephone, video,
internet or mobile application technologies [23], have re-
cently grown in popularity for promoting behaviour
change. Whittaker et al. [24] report that mobile phone-
based interventions for smoking cessation, primarily de-
livering support by text messages, increase the odds of
abstinence at 6 months by 70% compared to those who
did not receive the intervention. Similarly, internet inter-
ventions can be effective as an aid for smoking cessation,
particularly if they are interactive and tailored to meet
individual needs [25, 26]. Smartphone applications for
smoking cessation are becoming increasingly popular
[27]. However, the majority of existing smartphone apps
and Facebook apps for smoking cessation rarely adhere
to evidence-based practice [27–29]. A content analysis
of the use of self-determination theory (SDT) in smart-
phone apps for smoking cessation reported that many
current apps may also be missing the theoretical under-
pinning likely to make them most effective in the long
term [30]. Recent randomised controlled trials have used
small sample sizes and produced inconclusive results
when compared to other digital interventions, such as
text message interventions [31], making it difficult to as-
sess the full effectiveness of smartphone apps for general
smoking cessation [31, 32].
Digital interventions for smoking cessation in the gen-
eral population can be beneficial. However, smoking in
pregnancy may not be fully comparable to smoking in
the general population. Due to physiological changes
during pregnancy, such as blood levels of nicotine de-
creasing faster leading to more frequent nicotine with-
drawal, quitting whilst pregnant may be even more
difficult [33]. Smoking in pregnancy is closely linked to
determinants of low socioeconomic status such as edu-
cation, income, employment and social support net-
works [34]. Prenatal smoking is often used as a stress
management resource, providing brief moments of re-
laxation in stressful lives and situations [7], particularly
as pregnant women are likely to face internal and exter-
nal pressure to stop smoking for the health of their baby
[35]. In light of these issues, it is necessary to treat
smoking in pregnancy as a separate issue from smoking
in the general population and to collate research which
specifically targets smoking in pregnancy.
The technological features of digital interventions
make them relatively easy to tailor to the needs of the
individual [36], which is likely to contribute to the effect-
iveness of interventions to aid smoking cessation in
pregnancy [19, 20, 37, 38]. Digital interventions may also
have the potential to address barriers that pregnant
women face regarding seeking support to stop smoking,
such as fear of failure and fear of being judged [19], and
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the accessibility of services [19, 20, 39]. As a result,
digital interventions, such as SMS text message pro-
grammes (e.g. ‘MiQuit’, [40]) and mobile phone applica-
tions (e.g. ‘SmokeFree Baby’, [41]) have been developed
for smoking in pregnancy. A recent review on the con-
tent and effectiveness of text message and app-based
interventions for smoking cessation in pregnancy sum-
marised programme characteristics and functions of
available reviewed literature and programmes in-progress
[42]. However, this review shows limited effectiveness
data, reporting abstinence outcomes from only two text
message programmes. Whilst demonstrating the promise
of these interventions for smoking cessation in pregnancy,
there remains a lack of evidence evaluating the effective-
ness of such digital interventions. This highlights the need
to collate research across all types of digital interventions
for smoking cessation in pregnancy to ascertain whether
these types of interventions are effective and to identify
which approaches show most promise.
As highlighted in a review by Lorencatto et al. [43],
there is limited reporting of the specific components, or
behaviour change techniques (BCTs), that make up in-
terventions in current literature reviews. BCTs are the
smallest replicable components of an intervention,
which can be used individually or in combination to
alter or redirect the processes which are fundamental to
behaviour change [44]. Specifying and reporting BCTs
are important for enabling the accurate replication of ef-
fective interventions [44]. Lorencatto et al. [43] specified
the BCT content of effective behavioural interventions
for smoking cessation in pregnancy, using the smoking
cessation taxonomy [45], which includes ‘provide infor-
mation on the consequences of behaviour’ and ‘identify-
ing barriers and/or problem solving’. A review on
internet-based interventions for health promotion in the
general population reported that theory-based interven-
tions and interventions integrating more BCTs achieved
larger effects [46]. However, a review of interventions
addressing smoking, healthy eating and physical activity
that specifically targeted low-income groups found that
effective interventions tended to use fewer BCTs than
ineffective interventions [47]. This contrast in evidence
highlights how examining which BCTs have been used
in digital interventions for pregnant smokers, and ex-
ploring whether there is a relationship between the
number of BCTs used and intervention effectiveness will
enhance the current research.
This review aims to address the current gap in the lit-
erature by analysing the use of digital interventions for
smoking cessation in pregnancy. This will be done by
synthesising the range of digital interventions currently
being implemented and evaluating their effectiveness.
To address the lack of research examining the mecha-
nisms of these interventions, the BCT content of
included papers will be explored where possible. For this
review, we will be using the most up-to-date taxonomy:
BCT Taxonomy v1, developed by Michie et al. [44].
Objectives
This review aims to answer the following three research
questions relating to digital interventions for smoking
cessation in pregnancy.
Primary focus:
1. Are digital interventions more effective in increasing
smoking cessation rates in pregnancy than usual
care/other control groups?
Secondary focus:
2. Which BCTs/combinations of BCTs are associated
with the effectiveness of digital interventions for
smoking cessation in pregnancy?
3. Is the number of BCTs used associated with the
effectiveness of digital interventions for smoking
cessation in pregnancy?
Method
The PRISMA-P guidelines for systematic review pro-
tocols have been followed for this protocol [48] (see
Additional file 1).
Eligibility criteria
Randomised and quasi-randomised controlled trials (in-
cluding randomised pilot studies) will be included. Any
type of comparison group will be included. Usual care
for smoking cessation in pregnancy is typically brief
smoking cessation advice provided by a health profes-
sional; however, any method of usual care will be accept-
able for this review. If possible, trials using the same
method of usual care will be pooled into a subgroup
meta-analysis. If meta-analysis is not appropriate, usual
care will only be analysed in a qualitative synthesis. Tri-
als with more than one comparator will be included if at
least one of the experimental arms meets the digital
intervention inclusion criteria, as specified below.
For the purposes of this review, digital interventions
will include any intervention delivered largely through a
computer (PC or laptop), video or DVD, mobile tele-
phone or portable handheld device (e.g. tablet, iPad).
This includes, although is not limited to, email, videos,
DVDs, websites or web-based games, mobile or tablet
applications and SMS text messages or MMS multimedia
messages. Interventions must be aimed at women who
smoke in pregnancy, with smoking cessation as a mea-
sured outcome. These can be either delivered directly by
an external source, e.g. health professional, researcher,
peer, or family, or they can be self-administered.
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Interventions which include non-digital elements will be
included only if the digital component is the primary
element of the intervention and if any interaction with a
health professional/counsellor/researcher etc. is purely
to explain how the digital intervention works. Inter-
ventions which have been converted directly from a
non-digital format (e.g. self-help leaflets in digital
form) will be excluded.
Participants must be pregnant women at any stage of
pregnancy, who have reported currently smoking ciga-
rettes. As digital interventions designed to aid smoking
cessation in younger pregnant adolescents are likely to
be tailored to the specific needs of this age group, inter-
ventions focused specifically on participants under the
age of 16 will be excluded. However, interventions de-
signed for adults with no lower limit on age for enrol-
ment will be included. Any studies with only women
who have already quit smoking will be excluded. There
will be no timing restrictions on publications. Articles
must be written in English.
Outcome measures
The preferred primary outcome will be the latest avail-
able point prevalence smoking status measure at the end
of pregnancy, biochemically validated where possible or
self-reported, as this is the most common measure used
in smoking cessation literature. Prolonged abstinence
from a set quit date will also be acceptable, preferably
biochemically validated if available but self-report if not,
so as not to exclude relevant studies reporting the effect-
iveness of a digital intervention on smoking abstinence
in pregnancy.
Secondary data outcomes, if reported, include process
measures relating to smoking cessation, such as setting a
quit date and self-efficacy, and outcomes relating directly
to the intervention, such as intervention use.
Secondary, descriptive outcomes will be BCT content
of interventions and control groups. Where this infor-
mation is not provided in the text or appendices of
papers, the research authors will be contacted to ask
whether this information is available. If not, authors will
be asked for permission to code the relevant manuals for
the BCTs used, or coding of the intervention description
in the manuscript will be carried out.
Information sources
Electronic bibliographic databases will be searched be-
tween August 2016 and October 2016: Academic Search
Complete, ASSIA, CINAHL, The Cochrane Library,
EMBASE, Medline, PsycINFO, Scopus and Web of Sci-
ence. Both key words and database-specific subject
headings relating to ‘pregnancy’ and ‘smoking’, variations
of the term ‘digital’ covering computer, video, internet,
app, telephone and mobile phone, and variations for
‘randomised control trial’ will be searched. Boolean logic
using AND OR will be employed where appropriate.
Reference lists of studies identified for the review and
relevant published reviews will be searched by hand. Au-
thors of included studies will be contacted to determine
whether they are aware of any relevant, unpublished
articles that meet the inclusion criteria. Papers citing in-
cluded studies will also be examined. Authors may also
have to be asked for access to the intervention if access
is not provided in the paper. This would be to enable
two review authors to independently code the interven-
tions and usual care/control group for BCTs, if possible,
using the BCT Taxonomy v1 developed by Michie et al.
[44], if this has not already been done. If this is not pos-
sible, BCT content will be inferred by coding the inter-
vention description given in the manuscript.
The following research registers will be searched using
the inclusion criteria for recently completed, unpublished
clinical trials: National Institute for Health Research UK
Clinical Trials Gateway, ClinicalTrials.gov, and Current
Controlled Trials through the ISRCTN registry.
Search strategy
An information specialist has provided support for this
work to ensure the most exhaustive search terms have
been employed. An example of the CINAHL database
search strategy is provided in Additional file 2. This will
be amended for other databases using database-specific
subject headings, and keywords in both titles and ab-
stracts will be searched.
Data management and screening process
Data will be managed using EndNote software. Results
from the original search will be combined and alphabe-
tised, and duplications will be removed. The first author
(SG) will then independently screen all titles and/or
abstracts for the first phase of the review. A second
reviewer (KB) will perform a calibration exercise by
screening the first 100 titles and/or abstracts, or 10% of
results (whichever is greatest), using a checklist to iden-
tify relevant papers. The Kappa statistic will be calcu-
lated to measure agreement [49]. If this is below 0.80,
which can be used as a mark of strong agreement [50], a
second exercise will be carried out on a further 50, or
5% of results, and any remaining discrepancies will be
resolved following group discussion. For the second
phase, full-text reports of potentially relevant studies will
be obtained and independently checked against the in-
clusion criteria checklist by SG and another reviewer.
Any disagreement over the suitability of a paper will be
discussed with a third reviewer until consensus is
reached. Data extraction and assessment of eligibility of
studies for meta-analysis will then be carried out inde-
pendently by SG and another reviewer using a data
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extraction sheet for the third phase. Any discrepancies
will be discussed with a third reviewer if agreement is
not reached.
Quality assessment
The Cochrane Collaboration’s tool for assessing risk of
bias in randomised trials will be used by SG and another
reviewer and will be adapted to assess the validity of the
studies included in the review [51]. Studies will be
assessed against the criteria below and given either a
classification of low risk, medium risk or high risk of bias:
1. Sequence generation
2. Allocation concealment
3. Blinding of participants, personnel and outcome
assessors
4. Incomplete outcome data
5. Selective outcome reporting
6. Other sources of bias
Data extraction and synthesis
Key details from each paper which meets the inclusion
criteria will be extracted and synthesised into two groups:
1. Descriptive details of interventions that have been
developed for smoking cessation in pregnancy,
including study details, participant information,
mode of delivery and intervention and control
group details.
2. Details of the intervention content, which will be
specified by respective BCTs (where possible).
Coding will follow guidelines from Michie et al.
[44] by SG and another reviewer independently. For
studies using a control group, this will also be coded
for BCTs to establish whether BCTs used in the
intervention are specific to the intervention itself.
Any disagreements will be discussed until a consensus
is reached. Extracted data will then be synthesised.
If the research team are unable to contact the study
author and the manuscript does not provide
enough detail for coding BCTs, the study will only
be included in the initial meta-analysis of pooled
trials, if suitable.
Data analyses
Measures of treatment effect
The number of participants reporting to be abstinent
from each trial will be extracted and presented as odds
ratios as they have advantageous mathematical proper-
ties compared to risk ratios when dealing with low event
rates and are more commonly reported in smoking
cessation literature. An intention to treat basis will be
applied, where any missing participant data will be
assumed to be smokers (non-abstinent).
Statistical analysis
To address the primary objective relating to the effect-
iveness of digital interventions, if appropriate, a meta-
analysis will be carried out pooling effect sizes of trials
comparing a digital intervention to usual care or control
group. In order to carry out a meta-analysis, there will
need to be similar RCTs meeting the inclusion criteria:
studies must be focused on pregnant women, must be
an RCT or quasi-randomised controlled trial, must be a
digital intervention, must have a control group and
smoking cessation must be reported as an outcome.
Studies must also report event rates for effect size calcu-
lation. If the data from the intervention is not appropri-
ate for meta-analysis, only a narrative synthesis will be
carried out.
If data are suitable for meta-analysis, subgroup meta-
analyses will be carried out pooling studies which have
used particular BCTs, where it has been possible to code
for BCT content. This will address the second objective
regarding which BCTs or groups of BCTs are associated
with the effectiveness of digital interventions for smok-
ing cessation in pregnancy.
To address the third objective, if meta-analysis is
deemed possible, a logistic meta-regression will be used
to explore if a relationship exists between the number of
BCTs used and intervention effectiveness. Regression
coefficients and their test of significance will be re-
ported. If BCT data is not suitable for meta-analysis,
this information will only be included in the narrative
synthesis.
Heterogeneity
As interventions will differ, effects are considered to fall
on a distribution of effect sizes; therefore, a random
effects model will be adopted for the meta-analyses, esti-
mating intervention effects with 95% confidence inter-
vals (CIs) and significance at the 5% level. Heterogeneity
between studies will be assessed using the chi-squared
test and, if significant, analysis of the inconsistency index
(I2) will measure how much variation across studies is a
result of heterogeneity, rather than chance [52]: where I2 is
more than 50%, this will indicate significant heterogeneity.
Publication bias
Funnel plots and tests of asymmetry will be used to as-
sess publication bias [53]. If publication bias is detected,
Duval and Tweedie trim and fill statistics will be used to
adjust the effect size for missing studies.
Sensitivity analysis
Anticipated sensitivity analyses include limiting the pri-
mary analysis to biochemically validated outcomes only
if possible and excluding any trials considered borderline
with respect to the inclusion criteria.
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Summary of findings table
GRADE system principles will be used to assess the
quality of evidence regarding reported outcomes [54],
and a summary of findings table will be produced. Out-
comes are expected to include the latest available point
prevalence abstinence during pregnancy, process mea-
sures such as setting a quit date and self-efficacy, other
outcomes relating directly to the intervention, such as
intervention use, and BCT content of interventions and
control groups, if data is available.
Discussion
The use of digital technology for smoking cessation in
pregnancy is a new and expanding field, which will benefit
from the detailed synthesis of research proposed in this re-
view. Exploring the effectiveness of digital interventions,
and the use of and effectiveness of behaviour change tech-
niques, will provide a necessary addition to the current
research-base for smoking cessation in pregnancy
Limitations
The novelty of this field may result in a restricted num-
ber of studies meeting the inclusion criteria; included
studies may be small-scale or pilot RCTs using limited
sample sizes. However, it is expected that there will be
enough research to allow for a detailed exploration of
the effectiveness of a variety of digital interventions for
smoking cessation in pregnancy.
As issues have been raised regarding the accessibility of
some forms of digital interventions, such as the use of web-
sites and smartphone apps, among pregnant smokers from
lower socioeconomic backgrounds [55], it would be benefi-
cial to explore this in a quantitative analysis. Unfortunately,
it is unlikely that the data from this review will allow for a
quantitative assessment of the impact of socioeconomic
status, or mode of delivery, on intervention effectiveness
for smoking cessation in pregnancy. We will, however, seek
to explore these variables in a qualitative synthesis.
Strengths
The only known review to currently explore the use of
digital interventions for smoking cessation in pregnancy
has focused on limited modes of delivery, in particular text
messaging and mobile phone apps, and has largely only
looked at the content of such interventions [42]. This re-
view aims to go a step further by exploring the effective-
ness of all digital interventions and synthesising the
research to enhance the body of evidence in this field.
By analysing the BCT content of current digital inter-
ventions for smoking cessation in pregnancy, this review
aims to address gaps in existing research by assessing the
extent to which such interventions are theory-driven and
to determine whether theory-driven digital interventions
are more likely to be effective for smoking cessation in
pregnancy.
Potential implications
The findings from this systematic review may provide
greater understanding amongst those working in digital
health and smoking cessation, and smoking cessation in
pregnancy, regarding the content of interventions most
likely to be effective. Results are likely to be of value for
public health and may therefore have the potential to in-
fluence the local commissioning of services.
The review findings will also be used in the design of a
theory-based intervention aiming to address smoking in
pregnancy and will be valuable for others involved in the
design of interventions for this population. By guiding
the design of new digital interventions which are most
likely to be effective for helping pregnant women to quit
smoking, this will ultimately provide protective health
benefits for both mother and baby.
Registration
This systematic review has been registered with PROS-
PERO, an international prospective register of systematic
reviews: http://www.crd.york.ac.uk/PROSPERO/display_
record.asp?ID=CRD42016036201. Any changes to the
protocol will be amended on this register.
Additional files
Additional file 1: PRISMA-P checklist. This checklist includes a list of
recommended items to include in a systematic review protocol and
where these can be found in this protocol. (DOC 82.5 kb)
Additional file 2: CINAHL example full search strategy. This search
strategy will be adapted for each database. (DOCX 79.0 kb)
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